These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31468515)

  • 1. Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine.
    Duce JA; Zhu X; Jacobson LH; Beart PM
    Br J Pharmacol; 2019 Sep; 176(18):3409-3412. PubMed ID: 31468515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.
    Ittner LM; Klugmann M; Ke YD
    Br J Pharmacol; 2019 Sep; 176(18):3649-3665. PubMed ID: 30817847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating Alzheimer's disease by targeting iron.
    Nikseresht S; Bush AI; Ayton S
    Br J Pharmacol; 2019 Sep; 176(18):3622-3635. PubMed ID: 30632143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of microglia in Alzheimer's disease: a new dog in the fight.
    Moore Z; Taylor JM; Crack PJ
    Br J Pharmacol; 2019 Sep; 176(18):3533-3543. PubMed ID: 30445661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A short perspective on the long road to effective treatments for Alzheimer's disease.
    Reynolds DS
    Br J Pharmacol; 2019 Sep; 176(18):3636-3648. PubMed ID: 30657599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Don't forget astrocytes when targeting Alzheimer's disease.
    Sadick JS; Liddelow SA
    Br J Pharmacol; 2019 Sep; 176(18):3585-3598. PubMed ID: 30636042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline.
    Semerano A; Fernández-Ruiz J; Cortes-Canteli M; Moro MA
    Br J Pharmacol; 2024 Mar; 181(6):755-759. PubMed ID: 38204183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets.
    Nizami S; Hall-Roberts H; Warrier S; Cowley SA; Di Daniel E
    Br J Pharmacol; 2019 Sep; 176(18):3515-3532. PubMed ID: 30740661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid precursor protein-mediated mitochondrial regulation and Alzheimer's disease.
    Lopez Sanchez MIG; van Wijngaarden P; Trounce IA
    Br J Pharmacol; 2019 Sep; 176(18):3464-3474. PubMed ID: 30471088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets.
    Herman FJ; Simkovic S; Pasinetti GM
    Br J Pharmacol; 2019 Sep; 176(18):3558-3584. PubMed ID: 30632147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteostasis network provides targets for neurodegeneration.
    Newton TM; Duce JA; Bayle ED
    Br J Pharmacol; 2019 Sep; 176(18):3508-3514. PubMed ID: 30820936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.
    Perez Ortiz JM; Swerdlow RH
    Br J Pharmacol; 2019 Sep; 176(18):3489-3507. PubMed ID: 30675901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer's disease.
    Fitz NF; Nam KN; Koldamova R; Lefterov I
    Br J Pharmacol; 2019 Sep; 176(18):3599-3610. PubMed ID: 30924124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.
    Nalivaeva NN; Turner AJ
    Br J Pharmacol; 2019 Sep; 176(18):3447-3463. PubMed ID: 30710367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of memory enhancement through modulation of perineuronal nets.
    Duncan JA; Foster R; Kwok JCF
    Br J Pharmacol; 2019 Sep; 176(18):3611-3621. PubMed ID: 30924524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?
    García-Culebras A; Cuartero MI; Peña-Martínez C; Moraga A; Vázquez-Reyes S; de Castro-Millán FJ; Cortes-Canteli M; Lizasoain I; Moro MÁ
    Br J Pharmacol; 2024 Mar; 181(6):777-798. PubMed ID: 37282844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating the matrix.
    Whiteford JR; Arokiasamy S; De Rossi G
    Br J Pharmacol; 2019 Jan; 176(1):3-4. PubMed ID: 30525194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenoceptors-New roles for old players.
    Michel MC; Bond RA; Summers RJ
    Br J Pharmacol; 2019 Jul; 176(14):2339-2342. PubMed ID: 31240712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease.
    Bettinetti-Luque M; Trujillo-Estrada L; Garcia-Fuentes E; Andreo-Lopez J; Sanchez-Varo R; Garrido-Sánchez L; Gómez-Mediavilla Á; López MG; Garcia-Caballero M; Gutierrez A; Baglietto-Vargas D
    Br J Pharmacol; 2024 Mar; 181(6):840-878. PubMed ID: 37706346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids and their actions: An update.
    Alexander SPH; Molina-Holgado F
    Br J Pharmacol; 2019 May; 176(10):1359-1360. PubMed ID: 31032895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.